Abstract | OBJECTIVES: To determine if the use of intrawound vancomycin powder reduces surgical-site infection after open reduction and internal fixation of bicondylar tibial plateau, tibial pilon, and calcaneus fractures. DESIGN: Retrospective analysis. SETTING: Level I trauma center. PATIENTS: All fractures operatively treated from January 2011 to February 2015 were reviewed; 583 high-risk fractures were included, of which 35 received topical vancomycin powder. A previously published prospectively collected cohort of 235 similar high-risk fractures treated at our center from 2007 through 2010 served as a second comparison group. INTERVENTION: MAIN OUTCOME MEASUREMENTS: Deep surgical-site infection. Analyses used both univariate comparison of all patients and 1:2 matching analysis using both nearest neighbor and propensity-based matching. RESULTS: CONCLUSIONS: LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
|
Authors | Rabah Qadir, Timothy Costales, Max Coale, Alexandra Mulliken, Timothy Zerhusen Jr, Manjari Joshi, Renan C Castillo, Anthony R Carlini, Robert V O'Toole |
Journal | Journal of orthopaedic trauma
(J Orthop Trauma)
Vol. 35
Issue 1
Pg. 23-28
(01 01 2021)
ISSN: 1531-2291 [Electronic] United States |
PMID | 32898082
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. |
Chemical References |
- Anti-Bacterial Agents
- Powders
- Vancomycin
|
Topics |
- Anti-Bacterial Agents
(therapeutic use)
- Humans
- Powders
- Retrospective Studies
- Surgical Wound Infection
(drug therapy, epidemiology, prevention & control)
- Tibial Fractures
(drug therapy, surgery)
- Vancomycin
|